Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Genes & Cancer|February 15, 2011
Sanguinarine suppresses prostate tumor growth and inhibits survivin expressionMeng Sun, Wei Lou, Jae Yeon Chun, et al.
European Urology Focus|July 30, 2017
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus ConsortiumOscar Rodriguez Faba, Estefania Linares, Derya Tilki, et al.
Molecular Cancer Therapeutics|June 13, 2018
Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate CancerAlan P Lombard, Liangren Liu, Vito Cucchiara, et al.
The Journal of Biological Chemistry|December 1, 2011
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cellsNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Scientific Reports|March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancerMamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
European Urology|May 8, 2013
Lymphadenectomy for bladder cancer at the time of radical cystectomyDerya Tilki, Maurizio Brausi, Renzo Colombo, et al.
Journal for Immunotherapy of Cancer|May 5, 2023
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironmentPengfei Xu, Joy C Yang, Bo Chen, et al.
Molecular Cancer Therapeutics|May 21, 2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate CancerJinge Zhao, Shu Ning, Wei Lou, et al.
Translational Oncology|May 11, 2019
Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
European Urology|March 31, 2021
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate CancerAnbarasu Kumaraswamy, Katherine R Welker Leng, Thomas C Westbrook, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Genes & Cancer|February 15, 2011
Sanguinarine suppresses prostate tumor growth and inhibits survivin expressionMeng Sun, Wei Lou, Jae Yeon Chun, et al.
European Urology Focus|July 30, 2017
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus ConsortiumOscar Rodriguez Faba, Estefania Linares, Derya Tilki, et al.
Molecular Cancer Therapeutics|June 13, 2018
Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate CancerAlan P Lombard, Liangren Liu, Vito Cucchiara, et al.
The Journal of Biological Chemistry|December 1, 2011
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cellsNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Scientific Reports|March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancerMamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
European Urology|May 8, 2013
Lymphadenectomy for bladder cancer at the time of radical cystectomyDerya Tilki, Maurizio Brausi, Renzo Colombo, et al.
Journal for Immunotherapy of Cancer|May 5, 2023
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironmentPengfei Xu, Joy C Yang, Bo Chen, et al.
Molecular Cancer Therapeutics|May 21, 2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate CancerJinge Zhao, Shu Ning, Wei Lou, et al.
Translational Oncology|May 11, 2019
Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
European Urology|March 31, 2021
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate CancerAnbarasu Kumaraswamy, Katherine R Welker Leng, Thomas C Westbrook, et al.
Pageof 21